← SynDRA
FLUMETHASONE PIVALATE
SynDRA canonical compound SYN0023250 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | NR3C1 |
|---|
| Mechanism of action | glucocorticoid receptor agonist |
|---|
| Indication | dermatitis |
|---|
| Disease area | Dermatology |
|---|
All known targets
- NR3C1
- ESRRA
- ESRRB
- ESRRG
- SERPINA6
- PLA2G1B
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- AR
- PGR
- ACHE
- KDR
- TBXA2R
- SLCO1B3
- SLCO1B1
- SLC6A4
- SLC6A3
- SLC6A2
- PTGS1
- PDE4A
- PDE3A
- OPRM1
- NFE2L2
- MAOA
- KCNH2
- ADORA3
- IDH1
- HTR2B
- HTR1A
- HRH3
- GMNN
- F2
- ESR1
- DRD3
- DRD1
- CHRM2
- CHRM1
- ADRA2A
- ADRA1A
- TDP1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Glucocorticoids
- Hormones
- Anti-Inflammatory Agents
ATC classes
- D07A · CORTICOSTEROIDS, PLAIN
- D07X · CORTICOSTEROIDS, OTHER COMBINATIONS
- CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS
- CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS
- CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION
Cross-references
Synonyms
- LOCORTEN
- flumetasone pivalate
- flumethasone 21-pivalate
- locacorten
- locorten
- Flumetasone pivalate
- Flumethasone 21-pivalate
- NSC-107680
- Locorten
- Locorten-vioform
- Locacorten
- Lorinden
- Flumethasone pivalate (USP)
- KS-1138
- Locorten (TN)
- Flumetasone pivalate (JAN/BAN)
- Lpha.-methylpregna-1,4-diene-3,20-dione 21-pivalate
- Flumethasone-21-pivalate
- NSC 107680
- 0DV09X6F21
- CHEBI:31620
- NSC107680
- DTXCID2028931
- flumethasone dimethylpropionate
- RefChem:55207
- MLS000069558
- MLS001077304
- SMR000058824
- C27H36F2O6
- Flumetasone 21-pivalate
- UNII-0DV09X6F21
- Flumetasone pival
- Flumethasone pivalate [USAN:USP]
- NCGC00022408-03
- EINECS 217-901-1
- Flumetasone pivalate CRS
- Opera_ID_1461
Look up FLUMETHASONE PIVALATE in the interactive SynDRA portal →